Increased Reintervention After Infrainguinal Revascularization for Chronic Limb-Threatening Ischemia in Women

被引:7
|
作者
Wu, Bian [1 ]
Lancaster, Elizabeth M. [1 ]
Ramirez, Joel L. [1 ]
Zarkowsky, Devin S. [1 ]
Reyzelman, Alexander M. [1 ]
Gasper, Warren J. [1 ]
Conte, Michael S. [1 ]
Hiramoto, Jade S. [1 ]
机构
[1] Univ Calif San Francisco, Dept Surg, Div Vasc Surg, San Francisco, CA USA
关键词
PERIPHERAL ARTERIAL-DISEASE; VEIN GRAFT FAILURE; GENDER-DIFFERENCES; ENDOVASCULAR TREATMENT; RISK STRATIFICATION; OCCLUSIVE DISEASE; VASCULAR-DISEASE; SEX-DIFFERENCES; OUTCOMES; BYPASS;
D O I
10.1016/j.avsg.2020.06.006
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The objective of this study was to determine if there are gender-based differences in major adverse limb events after revascularization for chronic limb-threatening ischemia (CLTI) and to identify potential associated factors. Methods: This was a single-center retrospective analysis of 151 patients who underwent infrainguinal revascularization for CLTI between April 2013 and December 2015. Only the first revascularized limb was included in patients with bilateral CLTI. Demographic data and clinical outcomes were collected using electronic medical records. Results: The mean age was 68.1 +/- 12.1 years, and 55 of 151 (36%) were women. Women were less likely to carry a diagnosis of hyperlipidemia (60% vs. 83%; P = 0.003), less likely to be on a statin medication (58% vs. 81%; P = 0.004), and less likely to undergo an infrapopliteal revascularization (60% vs. 77%; P = 0.04) compared with men. There were no differences between genders with regard to the Society for Vascular Surgery Wound Ischemia and Foot Infection stage at presentation or utilization of open versus endovascular intervention. During the median follow-up time of 678 days (interquartile range, 167-1277 days), 48 of 151 patients (32%) underwent reintervention on the threatened limb and 23 of 151 patients (15%) underwent major amputation. Women were more likely than men to need reintervention (P = 0.02). There was no difference between genders for major amputation (P = 0.48) or overall survival (P = 0.65). In a multivariable Cox proportional hazards model for reintervention that included gender, preoperative body mass index, hyperlipidemia, preoperative anticoagulation, and ischemia score >= 2 (all P < 0.20 in univariate analysis), female gender (hazard ratio [HR], 1.96 [1.10-3.54]; P = 0.02) and hyperlipidemia (HR, 2.32 [1.07-5.03]; P = 0.03) were significantly associated with increased rates of reintervention. Conclusions: Women undergoing lower extremity revascularization for CLTI were more likely to require reintervention compared with men but had similar rates of limb preservation. Further study is required to understand potential causative factors to improve treatment outcomes in women.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 50 条
  • [41] The Impact of Chronic Limb-Threatening Ischemia on Cardiac Surgery
    Wakabayashi, Naohiro
    Kikuchi, Shinsuke
    Kuriyama, Naoya
    Kikuchi, Yuta
    Tsutsui, Masahiro
    Ise, Hayato
    Yoshida, Yuri
    Uchida, Daiki
    Koya, Atsuhiro
    Shirasaka, Tomonori
    Azuma, Nobuyoshi
    Kamiya, Hiroyuki
    FRONTIERS IN SURGERY, 2022, 9
  • [42] The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia
    El Khoury, Rym
    Wu, Bian
    Edwards, Ceazon T.
    Lancaster, Elizabeth M.
    Hiramoto, Jade S.
    Vartanian, Shant M.
    Schneider, Peter A.
    Conte, Michael S.
    JOURNAL OF VASCULAR SURGERY, 2021, 73 (06) : 2009 - +
  • [43] Discrepancy in Outcomes after Revascularization for Chronic Limb-Threatening Ischemia Warrants Separate Reporting of Rest Pain and Tissue Loss
    Brahmandam, Anand
    Gholitabar, Navid
    Cardella, Jonathan
    Nassiri, Naiem
    Dardik, Alan
    Georgi, Marc
    Chaar, Cassius Iyad Ochoa
    ANNALS OF VASCULAR SURGERY, 2021, 70 : 237 - 244
  • [44] Transitions of frailty after lower extremity interventions for chronic limb-threatening ischemia
    Hart, Joseph P.
    Davies, Mark G.
    JOURNAL OF VASCULAR SURGERY, 2025, 81 (03)
  • [45] Risk Factors for Major Amputation in Chronic Limb-Threatening Ischemia Patients Classified as Wound, Ischemia, and Foot Infection Stage 4 following Infrainguinal Revascularization
    Morisaki, Koichi
    Guntani, Atsushi
    Matsuda, Daisuke
    Matsubara, Yutaka
    Kinoshita, Go
    Kawanami, Shogo
    Yamashita, Sho
    Honma, Kenichi
    Yamaoka, Terutoshi
    Mii, Shinsuke
    Komori, Kimihiro
    Furuyama, Tadashi
    Yoshizumi, Tomoharu
    ANNALS OF VASCULAR SURGERY, 2023, 94 : 246 - 252
  • [46] Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia
    Naiem, Ahmed A.
    Bergeron, Ariane
    MacKenzie, Kent S.
    Obrand, Daniel I.
    Steinmetz, Oren K.
    Bayne, Jason P.
    Gill, Heather L.
    Girsowicz, Elie
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (03) : 858 - 863
  • [47] Delays to revascularization for patients with chronic limb-threatening ischaemia
    Li, Qiuju
    Birmpili, Panagiota
    Johal, Amundeep S.
    Waton, Sam
    Pherwani, Arun D.
    Boyle, Jonathan R.
    Cromwell, David A.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : 717 - 726
  • [48] The impact of travel distance in patient outcomes following revascularization for chronic limb-threatening ischemia
    Mota, Lucas
    Jayaram, Anusha
    Wu, Winona W.
    Roth, Eve M.
    Darling, Jeremy D.
    Hamdan, Allen D.
    Wyers, Mark C.
    Stangenberg, Lars
    Schermerhorn, Marc L.
    Liang, Patric
    JOURNAL OF VASCULAR SURGERY, 2024, 80 (06)
  • [49] How I do it: Pedal access and pedal loop revascularization for patients with chronic limb-threatening ischemia
    Kuroki, Marcos T.
    Parikh, Umang M.
    Chandra, Venita
    JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES, 2023, 9 (03):
  • [50] Narrative Review of Biological Markers in Chronic Limb-Threatening Ischemia
    Popescu, Alexandra Ioana
    Rata, Andreea Luciana
    Barac, Sorin
    Popescu, Roxana
    Onofrei, Roxana Ramona
    Vlad, Cristian
    Vlad, Daliborca
    BIOMEDICINES, 2024, 12 (04)